| Date | Form | Description | Docs | XBRL | Pages |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/21 | 8-K | Current report filing |
|
25 | |
| 03/24/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/23/21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
1 | |
| 03/22/21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
1 | |
| 03/22/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
Latest News & Events
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences Clarifies Poster Presentation on Company Website
Read More...Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Read More...